Creo Medical Group (LSE:CREO) ROE % Adjusted to Book Value : -11.32% (As of Dec. 2023)

View and export this data going back to 2016. Start your Free Trial

What is Creo Medical Group ROE % Adjusted to Book Value?

Creo Medical Group's ROE % for the quarter that ended in Dec. 2023 was -31.37%. Creo Medical Group's PB Ratio for the quarter that ended in Dec. 2023 was 2.77. Creo Medical Group's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2023 was -11.32%.

Creo Medical Group ROE % Adjusted to Book Value Historical Data

The historical data trend for Creo Medical Group's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Creo Medical Group ROE % Adjusted to Book Value Chart

Creo Medical Group Annual Data

Trend

Feb14

Feb15

Feb16

Jun17

Dec19

Dec20

Dec21

Dec22

Dec23

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

-9.94

-5.74

-9.82

-47.18

-14.36

Creo Medical Group Semi-Annual Data
	Feb14	Feb15	Feb16	Dec16	Jun17	Dec17	Jun18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
ROE % Adjusted to Book Value	Get a 7-Day Free Trial												-12.72	-14.71	-52.20	-22.03	-11.32

Competitive Comparison of Creo Medical Group's ROE % Adjusted to Book Value

For the Medical Devices subindustry, Creo Medical Group's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Creo Medical Group's ROE % Adjusted to Book Value Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Creo Medical Group's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Creo Medical Group's ROE % Adjusted to Book Value falls into.

Creo Medical Group ROE % Adjusted to Book Value Calculation

Creo Medical Group's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-39.78%	/	2.77
	=	-14.36%

Creo Medical Group's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-31.37%	/	2.77
	=	-11.32%

Creo Medical Group ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Creo Medical Group's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Creo Medical Group (LSE:CREO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Creo Medical Group PLC (LSE:CREO) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

N/A

Address

Beaufort Park Way, Unit 2, Creo House, Beaufort Park, Chepstow, GBR, NP16 5UH

Website

https://www.creomedical.com

Creo Medical Group PLC is a medical device company engaged in providing services in the field of surgical endoscopy. The company has developed a platform called Croma which is an electrosurgical platform to deliver microwave and bipolar radiofrequency through a single accessory port. The reportable segment of the company is the research and development of electrosurgical medical devices relating to the field of surgical endoscopy.

Creo Medical Group (LSE:CREO) Headlines

No Headlines